Camelot Portfolios’s Bausch Health BHC Stock Holding History

Camelot Portfolios’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,500	Closed	-$59.1K	–	232
2025 Q4	$59.1K	Buy	+8,500	New	+$55.9K	0.04%	299
2024 Q3	–	Sell	-8,500	Closed	-$59.2K	–	183
2024 Q2	$59.2K	Buy	+8,500	New	+$64.3K	0.03%	288
2023 Q4	–	Sell	-20,000	Closed	-$164K	–	211
2023 Q3	$164K	Sell	20,000 -8,500	-30%	-$73.3K	0.16%	122
2023 Q2	$228K	Buy	28,500 +7,000	+33%	+$51.6K	0.14%	163
2023 Q1	$174K	Hold	21,500	–	–	0.12%	161
2022 Q4	$135K	Buy	21,500 +5,000	+30%	+$34.9K	0.1%	160
2022 Q3	$114K	Sell	16,500 -7,500	-31%	-$52.1K	0.11%	147
2022 Q2	$201K	Buy	+24,000	New	+$336K	0.12%	192
2021 Q2	–	Sell	-10,270	Closed	-$326K	–	245
2021 Q1	$326K	Sell	10,270 -10,909	-52%	-$320K	0.14%	164
2020 Q4	$441K	Buy	21,179 +1,758	+9%	+$32.8K	0.23%	118
2020 Q3	$302K	Buy	+19,421	New	+$335K	0.19%	135

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Camelot Portfolios's BHC Position: Q1 2026 in Review

Camelot Portfolios sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 8,500 shares — an estimated $59.1K sold.

Camelot Portfolios first reported a position in BHC in Q3 2020 and held it in 11 quarters. The position peaked at $441K in Q4 2020. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

Camelot Portfolios reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
Camelot Portfolios sold 8,500 Bausch Health shares in Q1 2026, an estimated $59.1K.
Camelot Portfolios first reported a position in Bausch Health in Q3 2020 and held it in 11 quarters.
Camelot Portfolios's Bausch Health position peaked at $441K in Q4 2020.
227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.